Corvus hawaiiensis isolate bCorHaw1 chromosome 24, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036369.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
ankyrin repeat and SOCS box containing 8
ATP-dependent 6-phosphofructokinase, muscle type
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: collagen alpha-1(II) chain-like
transmembrane protein 106C, transcript variant X1
transmembrane protein 106C, transcript variant X2
Sp1 transcription factor, transcript variant X1
Sp1 transcription factor, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 4 codons; deleted 4 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 4 codons; deleted 4 bases in 4 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: anti-Muellerian hormone type-2 receptor
LOW QUALITY PROTEIN: poly(rC)-binding protein 2
mitogen-activated protein kinase kinase kinase 12
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mitogen-activated protein kinase kinase kinase 12
cyclic AMP-dependent transcription factor ATF-7-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cyclic AMP-dependent transcription factor ATF-7-like
ATP synthase F(0) complex subunit C2, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LOW QUALITY PROTEIN: homeobox protein Hox-C13
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins
LOW QUALITY PROTEIN: homeobox protein Hox-C12
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LOW QUALITY PROTEIN: homeobox protein Hox-C11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
transmembrane and death domain protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sodium voltage-gated channel alpha subunit 8
LOW QUALITY PROTEIN: sodium channel protein type 8 subunit alpha
putative methyltransferase-like protein 7A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
activating transcription factor 1, transcript variant X1
activating transcription factor 1, transcript variant X3
activating transcription factor 1, transcript variant X2
cyclic AMP-dependent transcription factor ATF-1 isoform X1
cyclic AMP-dependent transcription factor ATF-1 isoform X2
disco interacting protein 2 homolog B, transcript variant X5
disco interacting protein 2 homolog B, transcript variant X2
disco interacting protein 2 homolog B, transcript variant X1
disco interacting protein 2 homolog B, transcript variant X4
disco interacting protein 2 homolog B, transcript variant X3
disco-interacting protein 2 homolog B isoform X5
disco-interacting protein 2 homolog B isoform X2
disco-interacting protein 2 homolog B isoform X4
disco-interacting protein 2 homolog B isoform X1
disco-interacting protein 2 homolog B isoform X3
La ribonucleoprotein 4, transcript variant X5
La ribonucleoprotein 4, transcript variant X4
La ribonucleoprotein 4, transcript variant X2
La ribonucleoprotein 4, transcript variant X6
La ribonucleoprotein 4, transcript variant X3
La ribonucleoprotein 4, transcript variant X1
La ribonucleoprotein 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
LIM domain and actin binding 1, transcript variant X5
LIM domain and actin binding 1, transcript variant X4
LIM domain and actin binding 1, transcript variant X3
LIM domain and actin binding 1, transcript variant X1
LIM domain and actin binding 1, transcript variant X2
LIM domain and actin-binding protein 1 isoform X4
LIM domain and actin-binding protein 1 isoform X3
LIM domain and actin-binding protein 1 isoform X1
LIM domain and actin-binding protein 1 isoform X2
LIM domain and actin binding 1, transcript variant X6
LIM domain and actin-binding protein 1 isoform X5
ceramide synthase 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
ceramide synthase 5, transcript variant X1
ceramide synthase 5, transcript variant X2
cytochrome c oxidase assembly protein COX14 homolog, transcript variant X1
cytochrome c oxidase assembly protein COX14 homolog, transcript variant X2
cytochrome c oxidase assembly protein COX14 homolog
glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1
acid sensing ion channel subunit 1, transcript variant X4
acid sensing ion channel subunit 1, transcript variant X3
acid sensing ion channel subunit 1, transcript variant X2
acid sensing ion channel subunit 1, transcript variant X1
Rac GTPase activating protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Rac GTPase activating protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Rac GTPase activating protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
interferon-induced protein with tetratricopeptide repeats 1-like
histone deacetylase 7, transcript variant X2
histone deacetylase 7, transcript variant X4
histone deacetylase 7, transcript variant X1
histone deacetylase 7, transcript variant X3
histone deacetylase 7, transcript variant X6
histone deacetylase 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: heme transporter HRG1
Rap guanine nucleotide exchange factor 3
thymocyte expressed, positive selection associated 1, transcript variant X1
thymocyte expressed, positive selection associated 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
protein phosphatase 1 regulatory inhibitor subunit 1A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 1A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nck-associated protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein A1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
single-strand-selective monofunctional uracil-DNA glycosylase 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
LOW QUALITY PROTEIN: single-strand selective monofunctional uracil DNA glycosylase
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: SOSS complex subunit B1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain 52, transcript variant X3
ankyrin repeat domain 52, transcript variant X2
ankyrin repeat domain 52, transcript variant X1
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C isoform X3
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C isoform X2
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
coenzyme Q-binding protein COQ10 homolog A, mitochondrial
canopy FGF signaling regulator 2, transcript variant X4
canopy FGF signaling regulator 2, transcript variant X3
canopy FGF signaling regulator 2, transcript variant X2
canopy FGF signaling regulator 2, transcript variant X1
poly(A) specific ribonuclease subunit PAN2, transcript variant X4
poly(A) specific ribonuclease subunit PAN2, transcript variant X3
poly(A) specific ribonuclease subunit PAN2, transcript variant X2
poly(A) specific ribonuclease subunit PAN2, transcript variant X1
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X4
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X3
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X2
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
signal transducer and activator of transcription 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
signal transducer and activator of transcription 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
signal transducer and activator of transcription 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
signal transducer and activator of transcription 2, transcript variant X1
signal transducer and activator of transcription 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
signal transducer and activator of transcription 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
signal transducer and activator of transcription 2 isoform X2
signal transducer and activator of transcription 2 isoform X3
signal transducer and activator of transcription 2 isoform X1
timeless circadian regulator, transcript variant X6
timeless circadian regulator, transcript variant X3
timeless circadian regulator, transcript variant X5
timeless circadian regulator, transcript variant X4
timeless circadian regulator, transcript variant X1
timeless circadian regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RNA binding motif single stranded interacting protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: RNA-binding motif, single-stranded-interacting protein 2
bromodomain adjacent to zinc finger domain 2A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
LOW QUALITY PROTEIN: bromodomain adjacent to zinc finger domain protein 2A
ATP synthase subunit beta, mitochondrial
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00273
nascent polypeptide associated complex subunit alpha, transcript variant X3
nascent polypeptide associated complex subunit alpha, transcript variant X2
nascent polypeptide associated complex subunit alpha, transcript variant X4
nascent polypeptide associated complex subunit alpha, transcript variant X1
nascent polypeptide associated complex subunit alpha, transcript variant X5
nascent polypeptide-associated complex subunit alpha isoform X5
nascent polypeptide-associated complex subunit alpha isoform X3
nascent polypeptide-associated complex subunit alpha isoform X2
nascent polypeptide-associated complex subunit alpha isoform X4
nascent polypeptide-associated complex subunit alpha isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger and BTB domain containing 39
zinc finger and BTB domain-containing protein 39
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
nuclear envelope integral membrane protein 1
NGFI-A binding protein 2, transcript variant X1
NGFI-A binding protein 2, transcript variant X2
signal transducer and activator of transcription 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
signal transducer and activator of transcription 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
signal transducer and activator of transcription 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
signal transducer and activator of transcription 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
signal transducer and activator of transcription 6
LDL receptor related protein 1, transcript variant X1
LDL receptor related protein 1, transcript variant X2
prolow-density lipoprotein receptor-related protein 1 isoform X1
prolow-density lipoprotein receptor-related protein 1 isoform X2
LDL receptor related protein 1, transcript variant X3
prolow-density lipoprotein receptor-related protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine hydroxymethyltransferase, mitochondrial
NDUFA4 mitochondrial complex associated like 2, transcript variant X2
NDUFA4 mitochondrial complex associated like 2, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 isoform X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LOW QUALITY PROTEIN: SH3 and cysteine-rich domain-containing protein 3
R3H domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
R3H domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
R3H domain containing 2, transcript variant X1
R3H domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
R3H domain-containing protein 2 isoform X2
R3H domain-containing protein 2 isoform X3
R3H domain-containing protein 2 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: inhibin beta C chain-like
LOW QUALITY PROTEIN: zinc finger protein GLI1
limb development membrane protein 1 like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
lysine methyltransferase 2D, transcript variant X1
lysine methyltransferase 2D, transcript variant X6
lysine methyltransferase 2D, transcript variant X2
lysine methyltransferase 2D, transcript variant X7
lysine methyltransferase 2D, transcript variant X4
lysine methyltransferase 2D, transcript variant X3
lysine methyltransferase 2D, transcript variant X8
lysine methyltransferase 2D, transcript variant X5
histone-lysine N-methyltransferase 2D isoform X1
histone-lysine N-methyltransferase 2D isoform X6
histone-lysine N-methyltransferase 2D isoform X2
histone-lysine N-methyltransferase 2D isoform X7
histone-lysine N-methyltransferase 2D isoform X4
histone-lysine N-methyltransferase 2D isoform X3
histone-lysine N-methyltransferase 2D isoform X8
histone-lysine N-methyltransferase 2D isoform X5
protein kinase AMP-activated non-catalytic subunit gamma 1
5'-AMP-activated protein kinase subunit gamma-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP11
LOW QUALITY PROTEIN: probable ATP-dependent RNA helicase DDX23
calcium voltage-gated channel auxiliary subunit beta 3, transcript variant X1
calcium voltage-gated channel auxiliary subunit beta 3, transcript variant X2
voltage-dependent L-type calcium channel subunit beta-3 isoform X1
voltage-dependent L-type calcium channel subunit beta-3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 2, transcript variant X2
KAT8 regulatory NSL complex subunit 2, transcript variant X1
KAT8 regulatory NSL complex subunit 2, transcript variant X3
KAT8 regulatory NSL complex subunit 2 isoform X1
KAT8 regulatory NSL complex subunit 2 isoform X2
small nucleolar RNA SNORA2/SNORA34 family
COORDINATES: nucleotide motif:Rfam:12.0:RF00410
NCK associated protein 5 like, transcript variant X1
NCK associated protein 5 like, transcript variant X4
NCK associated protein 5 like, transcript variant X3
NCK associated protein 5 like, transcript variant X6
NCK associated protein 5 like, transcript variant X2
NCK associated protein 5 like, transcript variant X5
transmembrane BAX inhibitor motif containing 6
autophagy related 101, transcript variant X1
autophagy related 101, transcript variant X4
autophagy related 101, transcript variant X3
autophagy related 101, transcript variant X2
autophagy-related protein 101 isoform X1
autophagy-related protein 101 isoform X2
nuclear receptor subfamily 4 group A member 1, transcript variant X2
nuclear receptor subfamily 4 group A member 1, transcript variant X1
nuclear receptor subfamily 4 group A member 1 isoform X2
nuclear receptor subfamily 4 group A member 1 isoform X1
trafficking regulator and scaffold protein tamalin, transcript variant X2
trafficking regulator and scaffold protein tamalin, transcript variant X1
serine/threonine-protein kinase receptor R3
ankyrin repeat domain 33, transcript variant X2
ankyrin repeat domain 33, transcript variant X1
forkhead box protein J1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
forkhead box protein J1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
basic proline-rich protein-like, transcript variant X4
translation initiation factor IF-2-like isoform X4
basic proline-rich protein-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
translation initiation factor IF-2-like isoform X5
basic proline-rich protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
basic proline-rich protein-like, transcript variant X1
basic proline-rich protein-like, transcript variant X3
basic proline-rich protein-like isoform X2
basic proline-rich protein-like isoform X1
basic proline-rich protein-like isoform X3
LETM1 domain containing 1, transcript variant X2
LETM1 domain containing 1, transcript variant X1
LETM1 domain-containing protein 1 isoform X2
LETM1 domain-containing protein 1 isoform X1
LETM1 domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
LETM1 domain-containing protein 1 isoform X3
solute carrier family 11 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 11 member 2, transcript variant X2
natural resistance-associated macrophage protein 2 isoform X1
natural resistance-associated macrophage protein 2 isoform X2
solute carrier family 11 member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
solute carrier family 11 member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
natural resistance-associated macrophage protein 2 isoform X4
solute carrier family 11 member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
natural resistance-associated macrophage protein 2 isoform X3
Ts translation elongation factor, mitochondrial
LOW QUALITY PROTEIN: elongation factor Ts, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
methyltransferase 1, tRNA methylguanosine
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: tRNA (guanine-N(7)-)-methyltransferase
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
cyclin dependent kinase 4, transcript variant X3
cyclin dependent kinase 4, transcript variant X4
cyclin dependent kinase 4, transcript variant X1
cyclin dependent kinase 4, transcript variant X2
uridylate-specific endoribonuclease C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 73% coverage of the annotated genomic feature by RNAseq alignments
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 isoform X2
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 isoform X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 4 bases in 3 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
beta-1,4-N-acetyl-galactosaminyltransferase 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: beta-1,4 N-acetylgalactosaminyltransferase 1
cysteine and serine rich nuclear protein 2, transcript variant X1
cysteine and serine rich nuclear protein 2, transcript variant X3
cysteine and serine rich nuclear protein 2, transcript variant X2
DNA damage-inducible transcript 3 protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125338088, transcript variant X1
uncharacterized LOC125338088, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sulfite oxidase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
phosphatidylinositol-5-phosphate 4-kinase type 2 gamma
phosphatidylinositol 5-phosphate 4-kinase type-2 gamma
probable E3 ubiquitin-protein ligase DTX3
transcription factor CP2, transcript variant X2
transcription factor CP2, transcript variant X1
alpha-globin transcription factor CP2 isoform X2
alpha-globin transcription factor CP2 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 8 bases in 6 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 8 bases in 6 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: POU domain, class 6, transcription factor 1
small cell adhesion glycoprotein, transcript variant X2
small cell adhesion glycoprotein, transcript variant X1
small cell adhesion glycoprotein, transcript variant X3
small cell adhesion glycoprotein, transcript variant X5
small cell adhesion glycoprotein, transcript variant X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: bridging integrator 2
chymotrypsin-like elastase family member 1
polypeptide N-acetylgalactosaminyltransferase 6
LOW QUALITY PROTEIN: polypeptide N-acetylgalactosaminyltransferase 6
uncharacterized LOC125337749, transcript variant X1
uncharacterized LOC125337749, transcript variant X2
uncharacterized LOC125337749, transcript variant X3
uncharacterized protein LOC125337749 isoform X3
uncharacterized protein LOC125337749 isoform X1
uncharacterized protein LOC125337749 isoform X2
solute carrier family 4 member 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
solute carrier family 4 member 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
solute carrier family 4 member 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
electroneutral sodium bicarbonate exchanger 1 isoform X1
electroneutral sodium bicarbonate exchanger 1 isoform X2
electroneutral sodium bicarbonate exchanger 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
BCDIN3 domain containing RNA methyltransferase, transcript variant X1
BCDIN3 domain containing RNA methyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 187 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 5% coverage of the annotated genomic feature by RNAseq alignments
fibrous sheath CABYR-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 190 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
keratin, type II cytoskeletal 6C-like, transcript variant X2
keratin, type II cytoskeletal 6C-like, transcript variant X3
keratin, type II cytoskeletal 6C-like isoform X2
keratin, type II cytoskeletal 6C-like isoform X3
keratin, type II cytoskeletal 6C-like, transcript variant X1
keratin, type II cytoskeletal 6C-like isoform X1
LOW QUALITY PROTEIN: keratin, type II cytoskeletal 8-like
LOW QUALITY PROTEIN: keratin, type I cytoskeletal 18
eukaryotic translation initiation factor 4B, transcript variant X1
eukaryotic translation initiation factor 4B, transcript variant X2
eukaryotic translation initiation factor 4B isoform X1
eukaryotic translation initiation factor 4B isoform X2
BCL-6 corepressor-like protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
BCL-6 corepressor-like protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
leucine-rich repeat extensin-like protein 5 isoform X2
BCL-6 corepressor-like protein 1 isoform X1
cysteine sulfinic acid decarboxylase, transcript variant X3
cysteine sulfinic acid decarboxylase isoform X2
cysteine sulfinic acid decarboxylase, transcript variant X1
cysteine sulfinic acid decarboxylase, transcript variant X5
cysteine sulfinic acid decarboxylase, transcript variant X2
cysteine sulfinic acid decarboxylase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
cysteine sulfinic acid decarboxylase isoform X1
cysteine sulfinic acid decarboxylase isoform X4
cysteine sulfinic acid decarboxylase isoform X3
uncharacterized LOC125337950, transcript variant X2
uncharacterized LOC125337950, transcript variant X1
uncharacterized protein LOC125337950 isoform X2
uncharacterized protein LOC125337950 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger protein with KRAB and SCAN domains 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein kinase pim-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: serine/threonine-protein kinase pim-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
olfactory receptor 14J1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 105 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
olfactory receptor 14J1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 105 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein LOC125338028
EF-hand and coiled-coil domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125337845, transcript variant X1
uncharacterized LOC125337845, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
peptidylprolyl isomerase like 1, transcript variant X2
peptidylprolyl isomerase like 1, transcript variant X1
peptidyl-prolyl cis-trans isomerase-like 1 isoform X2
peptidyl-prolyl cis-trans isomerase-like 1 isoform X1
proline and serine rich coiled-coil 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
proline and serine rich coiled-coil 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
proline/serine-rich coiled-coil protein 1
cadherin EGF LAG seven-pass G-type receptor 2, transcript variant X2
cadherin EGF LAG seven-pass G-type receptor 2 isoform X2
cadherin EGF LAG seven-pass G-type receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cadherin EGF LAG seven-pass G-type receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
cadherin EGF LAG seven-pass G-type receptor 2 isoform X3
cadherin EGF LAG seven-pass G-type receptor 2 isoform X1
cadherin EGF LAG seven-pass G-type receptor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cadherin EGF LAG seven-pass G-type receptor 2 isoform X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
LOW QUALITY PROTEIN: serine--tRNA ligase, cytoplasmic
endosome-lysosome associated apoptosis and autophagy regulator 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
LOW QUALITY PROTEIN: endosome/lysosome-associated apoptosis and autophagy regulator 1
COORDINATES: nucleotide motif:Rfam:12.0:RF01268
transmembrane protein 167B, transcript variant X1
transmembrane protein 167B, transcript variant X2
innate immunity activator, transcript variant X5
innate immunity activator, transcript variant X4
innate immunity activator, transcript variant X1
innate immunity activator, transcript variant X3
innate immunity activator, transcript variant X2
innate immunity activator protein isoform X1
innate immunity activator protein isoform X3
innate immunity activator protein isoform X2
innate immunity activator protein isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
myb-related transcription factor, partner of profilin-like
translocase of inner mitochondrial membrane 17A
mitochondrial import inner membrane translocase subunit Tim17-A
adiponectin receptor 1, transcript variant X1
adiponectin receptor protein 1 isoform X1
adiponectin receptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
adiponectin receptor protein 1 isoform X2
ubiquitin conjugating enzyme E2 T, transcript variant X1
ubiquitin conjugating enzyme E2 T, transcript variant X2
ubiquitin conjugating enzyme E2 T, transcript variant X3
ubiquitin conjugating enzyme E2 T, transcript variant X5
ubiquitin conjugating enzyme E2 T, transcript variant X4
cryptochrome-1-like, transcript variant X4
cryptochrome-1-like, transcript variant X2
cryptochrome-1-like, transcript variant X3
cryptochrome-1-like, transcript variant X1
ligand dependent nuclear receptor interacting factor 1, transcript variant X2
ligand dependent nuclear receptor interacting factor 1, transcript variant X1
ligand dependent nuclear receptor interacting factor 1, transcript variant X4
ligand dependent nuclear receptor interacting factor 1, transcript variant X3
ligand-dependent nuclear receptor-interacting factor 1 isoform X1
ligand-dependent nuclear receptor-interacting factor 1 isoform X2
DNA damage regulated autophagy modulator 2, transcript variant X1
DNA damage regulated autophagy modulator 2, transcript variant X2
DNA damage-regulated autophagy modulator protein 2 isoform X2
DNA damage-regulated autophagy modulator protein 2 isoform X1
choline/ethanolamine phosphotransferase 1, transcript variant X1
choline/ethanolamine phosphotransferase 1, transcript variant X2
choline/ethanolaminephosphotransferase 1 isoform X1
choline/ethanolaminephosphotransferase 1 isoform X2
myosin binding protein H, transcript variant X2
myosin binding protein H, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PTPRF interacting protein alpha 4, transcript variant X8
PTPRF interacting protein alpha 4, transcript variant X5
PTPRF interacting protein alpha 4, transcript variant X7
PTPRF interacting protein alpha 4, transcript variant X6
PTPRF interacting protein alpha 4, transcript variant X4
PTPRF interacting protein alpha 4, transcript variant X3
PTPRF interacting protein alpha 4, transcript variant X2
PTPRF interacting protein alpha 4, transcript variant X1
PTPRF interacting protein alpha 4, transcript variant X10
PTPRF interacting protein alpha 4, transcript variant X9
PTPRF interacting protein alpha 4, transcript variant X11
PTPRF interacting protein alpha 4, transcript variant X12
transmembrane protein 183A, transcript variant X1
transmembrane protein 183A, transcript variant X2
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X2
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X1
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X3
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X4
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like isoform X1
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X6
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X5
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X7
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like isoform X4
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X8
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like isoform X2
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like isoform X3
transmembrane protein 9, transcript variant X1
transmembrane protein 9, transcript variant X2
proton-transporting V-type ATPase complex assembly regulator TMEM9
immunoglobulin like and fibronectin type III domain containing 1
immunoglobulin-like and fibronectin type III domain-containing protein 1
troponin T2, cardiac type, transcript variant X5
troponin T2, cardiac type, transcript variant X3
troponin T2, cardiac type, transcript variant X2
troponin T2, cardiac type, transcript variant X1
troponin T2, cardiac type, transcript variant X4
troponin T2, cardiac type, transcript variant X6
troponin I1, slow skeletal type, transcript variant X2
troponin I1, slow skeletal type, transcript variant X1
troponin I1, slow skeletal type, transcript variant X3
troponin I, slow skeletal muscle isoform X1
troponin I, slow skeletal muscle isoform X2
pleckstrin homology like domain family A member 3
pleckstrin homology-like domain family A member 3
serine/threonine-protein phosphatase 4 regulatory subunit 3B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 64% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 1 regulatory subunit 12B, transcript variant X4
protein phosphatase 1 regulatory subunit 12B, transcript variant X3
protein phosphatase 1 regulatory subunit 12B, transcript variant X1
protein phosphatase 1 regulatory subunit 12B, transcript variant X5
protein phosphatase 1 regulatory subunit 12B, transcript variant X2
protein phosphatase 1 regulatory subunit 12B, transcript variant X6
protein phosphatase 1 regulatory subunit 12B isoform X2
protein phosphatase 1 regulatory subunit 12B isoform X3
protein phosphatase 1 regulatory subunit 12B isoform X1
protein phosphatase 1 regulatory subunit 12B isoform X5
protein phosphatase 1 regulatory subunit 12B isoform X6
protein phosphatase 1 regulatory subunit 12B isoform X4
protein phosphatase 1 regulatory subunit 12B, transcript variant X7
protein phosphatase 1 regulatory subunit 12B isoform X7
neuron navigator 1, transcript variant X7
neuron navigator 1, transcript variant X4
neuron navigator 1, transcript variant X2
neuron navigator 1, transcript variant X6
neuron navigator 1, transcript variant X5
neuron navigator 1, transcript variant X3
neuron navigator 1, transcript variant X1
leucine zipper like transcription regulator 1, transcript variant X1
leucine-zipper-like transcriptional regulator 1 isoform X1
leucine zipper like transcription regulator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
leucine-zipper-like transcriptional regulator 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
leucine rich repeat containing G protein-coupled receptor 6, transcript variant X2
leucine rich repeat containing G protein-coupled receptor 6, transcript variant X1
leucine-rich repeat-containing G-protein coupled receptor 6 isoform X2
leucine-rich repeat-containing G-protein coupled receptor 6 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
receptor-type tyrosine-protein phosphatase V-like, transcript variant X2
receptor-type tyrosine-protein phosphatase V-like, transcript variant X3
receptor-type tyrosine-protein phosphatase V-like, transcript variant X4
receptor-type tyrosine-protein phosphatase V-like, transcript variant X1
receptor-type tyrosine-protein phosphatase V-like isoform X3
receptor-type tyrosine-protein phosphatase V-like isoform X2
receptor-type tyrosine-protein phosphatase V-like isoform X1
receptor-type tyrosine-protein phosphatase V-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase V-like isoform X4
protein tyrosine phosphatase non-receptor type 7, transcript variant X5
protein tyrosine phosphatase non-receptor type 7, transcript variant X4
protein tyrosine phosphatase non-receptor type 7, transcript variant X1
protein tyrosine phosphatase non-receptor type 7, transcript variant X2
protein tyrosine phosphatase non-receptor type 7, transcript variant X6
protein tyrosine phosphatase non-receptor type 7, transcript variant X3
tyrosine-protein phosphatase non-receptor type 7
E74 like ETS transcription factor 3, transcript variant X2
E74 like ETS transcription factor 3, transcript variant X1
ETS-related transcription factor Elf-3 isoform X2
ETS-related transcription factor Elf-3 isoform X1
kinesin family member 21B, transcript variant X5
kinesin family member 21B, transcript variant X3
kinesin family member 21B, transcript variant X4
kinesin family member 21B, transcript variant X2
kinesin family member 21B, transcript variant X1
calcium voltage-gated channel subunit alpha1 S, transcript variant X3
calcium voltage-gated channel subunit alpha1 S, transcript variant X2
calcium voltage-gated channel subunit alpha1 S, transcript variant X1
voltage-dependent L-type calcium channel subunit alpha-1S isoform X2
voltage-dependent L-type calcium channel subunit alpha-1S isoform X1
voltage-dependent L-type calcium channel subunit alpha-1S isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: amphoterin-induced protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
G protein subunit alpha i3, transcript variant X2
G protein subunit alpha i3, transcript variant X1
guanine nucleotide-binding protein G(i) subunit alpha-3
guanine nucleotide-binding protein G(t) subunit alpha-2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
epidermal growth factor receptor kinase substrate 8-like protein 3
uncharacterized LOC125338106, transcript variant X3
uncharacterized LOC125338106, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125338106, transcript variant X1
colony stimulating factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
colony stimulating factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
macrophage colony-stimulating factor 1 isoform X1
macrophage colony-stimulating factor 1 isoform X2
adenosylhomocysteinase like 1, transcript variant X1
adenosylhomocysteinase like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
S-adenosylhomocysteine hydrolase-like protein 1 isoform X1
S-adenosylhomocysteine hydrolase-like protein 1 isoform X2
adenosylhomocysteinase like 1, transcript variant X3
adenosylhomocysteinase like 1, transcript variant X4
S-adenosylhomocysteine hydrolase-like protein 1 isoform X3
striatin interacting protein 1, transcript variant X3
striatin-interacting protein 1 isoform X3
striatin interacting protein 1, transcript variant X1
striatin-interacting protein 1 isoform X1
striatin interacting protein 1, transcript variant X2
striatin-interacting protein 1 isoform X2
striatin interacting protein 1, transcript variant X4
striatin-interacting protein 1 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
sodium-dependent neutral amino acid transporter SLC6A17
potassium voltage-gated channel subfamily C member 4, transcript variant X2
potassium voltage-gated channel subfamily C member 4 isoform X2
potassium voltage-gated channel subfamily C member 4, transcript variant X1
potassium voltage-gated channel subfamily C member 4 isoform X1
potassium voltage-gated channel subfamily C member 4, transcript variant X3
potassium voltage-gated channel subfamily C member 4 isoform X3
RNA binding motif protein 15, transcript variant X2
RNA binding motif protein 15, transcript variant X3
RNA binding motif protein 15, transcript variant X1
RNA binding motif protein 15, transcript variant X4
RNA binding motif protein 15, transcript variant X5
RNA binding motif protein 15, transcript variant X6
solute carrier family 16 member 4, transcript variant X9
solute carrier family 16 member 4, transcript variant X1
solute carrier family 16 member 4, transcript variant X8
solute carrier family 16 member 4, transcript variant X7
solute carrier family 16 member 4, transcript variant X4
solute carrier family 16 member 4, transcript variant X5
solute carrier family 16 member 4, transcript variant X6
monocarboxylate transporter 5 isoform X9
monocarboxylate transporter 5 isoform X8
monocarboxylate transporter 5 isoform X6
monocarboxylate transporter 5 isoform X4
monocarboxylate transporter 5 isoform X5
monocarboxylate transporter 5 isoform X1
monocarboxylate transporter 5 isoform X7
solute carrier family 16 member 4, transcript variant X10
solute carrier family 16 member 4, transcript variant X3
monocarboxylate transporter 5 isoform X3
monocarboxylate transporter 5 isoform X10
solute carrier family 16 member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
monocarboxylate transporter 5 isoform X2
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily A member 10, transcript variant X1
potassium voltage-gated channel subfamily A member 10, transcript variant X2
potassium voltage-gated channel subfamily A member 10
potassium voltage-gated channel subfamily A member 2, transcript variant X2
potassium voltage-gated channel subfamily A member 2, transcript variant X5
potassium voltage-gated channel subfamily A member 2, transcript variant X6
potassium voltage-gated channel subfamily A member 2, transcript variant X1
potassium voltage-gated channel subfamily A member 2, transcript variant X3
potassium voltage-gated channel subfamily A member 2, transcript variant X4
potassium voltage-gated channel subfamily A member 2
potassium voltage-gated channel subfamily A member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
patatin like phospholipase domain containing 1, transcript variant X1
omega-hydroxyceramide transacylase isoform X1
patatin like phospholipase domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
omega-hydroxyceramide transacylase isoform X2
apoptosis facilitator Bcl-2-like protein 14
ETS variant transcription factor 7, transcript variant X1
ETS variant transcription factor 7, transcript variant X3
ETS variant transcription factor 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
potassium channel tetramerization domain containing 20, transcript variant X2
potassium channel tetramerization domain containing 20, transcript variant X3
potassium channel tetramerization domain containing 20, transcript variant X1
potassium channel tetramerization domain containing 20, transcript variant X5
BTB/POZ domain-containing protein KCTD20 isoform X1
BTB/POZ domain-containing protein KCTD20 isoform X3
potassium channel tetramerization domain containing 20, transcript variant X4
BTB/POZ domain-containing protein KCTD20 isoform X2
serine/threonine kinase 38, transcript variant X3
serine/threonine kinase 38, transcript variant X2
serine/threonine kinase 38, transcript variant X1
serine/threonine-protein kinase 38 isoform X2
serine/threonine-protein kinase 38 isoform X1
serine and arginine rich splicing factor 3
RAB44, member RAS oncogene family, transcript variant X1
RAB44, member RAS oncogene family, transcript variant X2
chromosome 24 C6orf89 homolog, transcript variant X2
chromosome 24 C6orf89 homolog, transcript variant X1
bombesin receptor-activated protein C6orf89 homolog
peptidase inhibitor 16-like, transcript variant X1
peptidase inhibitor 16-like, transcript variant X2
FYVE, RhoGEF and PH domain containing 2, transcript variant X1
FYVE, RhoGEF and PH domain containing 2, transcript variant X2
FYVE, RhoGEF and PH domain-containing protein 2 isoform X1
FYVE, RhoGEF and PH domain-containing protein 2 isoform X2
Pim-1 proto-oncogene, serine/threonine kinase
nerve growth factor, transcript variant X1
nerve growth factor, transcript variant X2
thyroid stimulating hormone subunit beta, transcript variant X1
thyroid stimulating hormone subunit beta, transcript variant X2
suppressor of IKBKE 1, transcript variant X3
suppressor of IKBKE 1, transcript variant X1
suppressor of IKBKE 1, transcript variant X2
suppressor of IKBKE 1, transcript variant X4
cold shock domain containing E1, transcript variant X1
cold shock domain containing E1, transcript variant X2
cold shock domain-containing protein E1 isoform X1
cold shock domain-containing protein E1 isoform X2
adenosine monophosphate deaminase 1, transcript variant X1
adenosine monophosphate deaminase 1, transcript variant X2
adenosine monophosphate deaminase 1, transcript variant X3
DENN domain containing 2C, transcript variant X8
DENN domain containing 2C, transcript variant X7
DENN domain containing 2C, transcript variant X2
DENN domain containing 2C, transcript variant X3
DENN domain containing 2C, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DENN domain containing 2C, transcript variant X1
DENN domain containing 2C, transcript variant X4
DENN domain containing 2C, transcript variant X5
DENN domain-containing protein 2C isoform X1
DENN domain-containing protein 2C isoform X2
DENN domain-containing protein 2C isoform X3
olfactomedin like 3, transcript variant X1
olfactomedin like 3, transcript variant X2
homeodomain interacting protein kinase 1, transcript variant X4
homeodomain interacting protein kinase 1, transcript variant X3
homeodomain interacting protein kinase 1, transcript variant X2
homeodomain interacting protein kinase 1, transcript variant X1
homeodomain-interacting protein kinase 1 isoform X4
homeodomain-interacting protein kinase 1 isoform X3
homeodomain-interacting protein kinase 1 isoform X2
homeodomain-interacting protein kinase 1 isoform X1
adaptor related protein complex 4 subunit beta 1
protein tyrosine phosphatase non-receptor type 22
tyrosine-protein phosphatase non-receptor type 22
uncharacterized LOC125338108, transcript variant X2
uncharacterized LOC125338108, transcript variant X1
putative homeodomain transcription factor 1
bromodomain and PHD finger containing 3, transcript variant X4
bromodomain and PHD finger containing 3, transcript variant X3
bromodomain and PHD finger containing 3, transcript variant X2
bromodomain and PHD finger containing 3, transcript variant X5
bromodomain and PHD finger containing 3, transcript variant X1
bromodomain and PHD finger-containing protein 3 isoform X1
bromodomain and PHD finger-containing protein 3 isoform X2
mitogen-activated protein kinase 14, transcript variant X2
mitogen-activated protein kinase 14, transcript variant X1
mitogen-activated protein kinase 14 isoform X2
mitogen-activated protein kinase 14 isoform X1
LHFPL tetraspan subfamily member 5, transcript variant X2
LHFPL tetraspan subfamily member 5, transcript variant X1
LHFPL tetraspan subfamily member 5 protein isoform X2
LHFPL tetraspan subfamily member 5 protein isoform X1
FKBP prolyl isomerase 5, transcript variant X2
FKBP prolyl isomerase 5, transcript variant X1
peptidyl-prolyl cis-trans isomerase FKBP5
TUB like protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
TUB like protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
TUB like protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TEA domain transcription factor 3, transcript variant X4
TEA domain transcription factor 3, transcript variant X5
TEA domain transcription factor 3, transcript variant X6
TEA domain transcription factor 3, transcript variant X1
TEA domain transcription factor 3, transcript variant X2
TEA domain transcription factor 3, transcript variant X3
transcriptional enhancer factor TEF-5 isoform X1
transcriptional enhancer factor TEF-5 isoform X3
transcriptional enhancer factor TEF-5 isoform X2
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X4
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X2
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X3
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X5
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X6
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X1
inositol 1,4,5-triphosphate receptor associated 1-like, transcript variant X1
inositol 1,4,5-triphosphate receptor associated 1-like, transcript variant X3
inositol 1,4,5-triphosphate receptor associated 1-like, transcript variant X4
inositol 1,4,5-triphosphate receptor associated 1-like, transcript variant X2
inositol 1,4,5-triphosphate receptor associated 1-like isoform X1
inositol 1,4,5-triphosphate receptor associated 1-like isoform X2
inositol 1,4,5-triphosphate receptor associated 1-like, transcript variant X5
FA complementation group E, transcript variant X1
FA complementation group E, transcript variant X4
FA complementation group E, transcript variant X2
Fanconi anemia group E protein isoform X3
Fanconi anemia group E protein isoform X1
FA complementation group E, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Fanconi anemia group E protein isoform X2
putative E3 ubiquitin-protein ligase makorin-4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
putative E3 ubiquitin-protein ligase makorin-4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein LOC125338132 isoform X2
putative E3 ubiquitin-protein ligase makorin-4 isoform X1
peroxisome proliferator activated receptor delta, transcript variant X2
peroxisome proliferator activated receptor delta, transcript variant X5
peroxisome proliferator activated receptor delta, transcript variant X1
peroxisome proliferator activated receptor delta, transcript variant X3
peroxisome proliferator activated receptor delta, transcript variant X4
peroxisome proliferator-activated receptor delta isoform X2
peroxisome proliferator-activated receptor delta isoform X1
peroxisome proliferator-activated receptor delta isoform X3
differentially expressed in FDCP 6 homolog
zinc finger protein 76, transcript variant X3
zinc finger protein 76, transcript variant X6
zinc finger protein 76, transcript variant X4
zinc finger protein 76, transcript variant X2
zinc finger protein 76, transcript variant X5
zinc finger protein 76, transcript variant X1
ribosomal protein L10a, transcript variant X1
ribosomal protein L10a, transcript variant X2
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X2
signal peptide, CUB domain and EGF like domain containing 3, transcript variant X1
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X2
signal peptide, CUB and EGF-like domain-containing protein 3 isoform X1
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X4
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X8
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X5
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X3
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X2
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X1
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X7
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X6
ankyrin repeat and SAM domain-containing protein 1A isoform X3
ankyrin repeat and SAM domain-containing protein 1A isoform X2
ankyrin repeat and SAM domain-containing protein 1A isoform X4
ankyrin repeat and SAM domain-containing protein 1A isoform X8
ankyrin repeat and SAM domain-containing protein 1A isoform X5
ankyrin repeat and SAM domain-containing protein 1A isoform X1
ankyrin repeat and SAM domain-containing protein 1A isoform X7
ankyrin repeat and SAM domain-containing protein 1A isoform X6
TATA-box binding protein associated factor 11, transcript variant X1
TATA-box binding protein associated factor 11, transcript variant X2
transcription initiation factor TFIID subunit 11 isoform X1
transcription initiation factor TFIID subunit 11 isoform X2
UHRF1 binding protein 1, transcript variant X1
UHRF1 binding protein 1, transcript variant X2
small nuclear ribonucleoprotein polypeptide C
inflammation and lipid regulator with UBA-like and NBR1-like domains
SAM pointed domain containing ETS transcription factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SAM pointed domain-containing Ets transcription factor
protein kinase C and casein kinase substrate in neurons 1
protein kinase C and casein kinase substrate in neurons protein 1
diphosphoinositol polyphosphate phosphohydrolase 1
high mobility group AT-hook 1, transcript variant X2
high mobility group protein HMG-I/HMG-Y isoform X2
high mobility group AT-hook 1, transcript variant X3
high mobility group AT-hook 1, transcript variant X4
high mobility group AT-hook 1, transcript variant X1
high mobility group protein HMG-I/HMG-Y isoform X1
high mobility group protein HMG-I/HMG-Y isoform X3
glutamate metabotropic receptor 4, transcript variant X1
glutamate metabotropic receptor 4, transcript variant X3
glutamate metabotropic receptor 4, transcript variant X2
metabotropic glutamate receptor 4 isoform X1
glutamate metabotropic receptor 4, transcript variant X4
metabotropic glutamate receptor 4 isoform X2
uncharacterized LOC125338084, transcript variant X1
uncharacterized LOC125338084, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
LEM domain nuclear envelope protein 2, transcript variant X1
LEM domain nuclear envelope protein 2, transcript variant X2
LEM domain-containing protein 2 isoform X1
LEM domain-containing protein 2 isoform X2
ubiquinol-cytochrome-c reductase complex assembly factor 2
inositol 1,4,5-trisphosphate receptor type 3
BCL2 antagonist/killer 1, transcript variant X1
BCL2 antagonist/killer 1, transcript variant X2
apolipoprotein B mRNA editing enzyme catalytic subunit 2, transcript variant X2
apolipoprotein B mRNA editing enzyme catalytic subunit 2, transcript variant X1
nuclear transcription factor Y subunit alpha, transcript variant X1
nuclear transcription factor Y subunit alpha, transcript variant X5
nuclear transcription factor Y subunit alpha, transcript variant X3
nuclear transcription factor Y subunit alpha, transcript variant X4
nuclear transcription factor Y subunit alpha, transcript variant X6
nuclear transcription factor Y subunit alpha, transcript variant X7
nuclear transcription factor Y subunit alpha, transcript variant X8
nuclear transcription factor Y subunit alpha, transcript variant X9
nuclear transcription factor Y subunit alpha, transcript variant X2
nuclear transcription factor Y subunit alpha isoform X1
nuclear transcription factor Y subunit alpha isoform X4
nuclear transcription factor Y subunit alpha isoform X7
nuclear transcription factor Y subunit alpha isoform X2
nuclear transcription factor Y subunit alpha isoform X3
nuclear transcription factor Y subunit alpha isoform X5
nuclear transcription factor Y subunit alpha isoform X6
nuclear transcription factor Y subunit alpha isoform X8
triggering receptor expressed on myeloid cells 2, transcript variant X2
triggering receptor expressed on myeloid cells 2, transcript variant X1
triggering receptor expressed on myeloid cells 2 isoform X2
triggering receptor expressed on myeloid cells 2 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons
LOW QUALITY PROTEIN: forkhead box protein P4
MyoD family inhibitor, transcript variant X2
MyoD family inhibitor, transcript variant X1
transcription factor EB, transcript variant X1
transcription factor EB, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fibroblast growth factor receptor substrate 3, transcript variant X1
fibroblast growth factor receptor substrate 3 isoform X1
fibroblast growth factor receptor substrate 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
fibroblast growth factor receptor substrate 3 isoform X2
prickle planar cell polarity protein 4, transcript variant X1
prickle planar cell polarity protein 4, transcript variant X2
prickle planar cell polarity protein 4, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 7 bases in 4 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 7 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: basic proline-rich protein-like
translocase of outer mitochondrial membrane 6, transcript variant X1
translocase of outer mitochondrial membrane 6, transcript variant X2
mitochondrial import receptor subunit TOM6 homolog
ubiquitin specific peptidase 49, transcript variant X5
ubiquitin specific peptidase 49, transcript variant X3
ubiquitin specific peptidase 49, transcript variant X4
ubiquitin specific peptidase 49, transcript variant X7
ubiquitin specific peptidase 49, transcript variant X6
ubiquitin specific peptidase 49, transcript variant X2
ubiquitin specific peptidase 49, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 49 isoform X1
ubiquitin specific peptidase 49, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 49 isoform X2
mediator complex subunit 20, transcript variant X2
mediator complex subunit 20, transcript variant X1
mediator of RNA polymerase II transcription subunit 20 isoform X2
mediator of RNA polymerase II transcription subunit 20 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
TATA-box binding protein associated factor 8
transcription initiation factor TFIID subunit 8
primary cilia formation, transcript variant X2
primary cilia formation, transcript variant X3
primary cilia formation, transcript variant X1
acidic mammalian chitinase-like, transcript variant X3
acidic mammalian chitinase-like, transcript variant X2
acidic mammalian chitinase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
proline and arginine rich end leucine rich repeat protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATPase plasma membrane Ca2+ transporting 4, transcript variant X6
ATPase plasma membrane Ca2+ transporting 4, transcript variant X1
ATPase plasma membrane Ca2+ transporting 4, transcript variant X5
ATPase plasma membrane Ca2+ transporting 4, transcript variant X2
ATPase plasma membrane Ca2+ transporting 4, transcript variant X3
ATPase plasma membrane Ca2+ transporting 4, transcript variant X4
plasma membrane calcium-transporting ATPase 4 isoform X1
plasma membrane calcium-transporting ATPase 4 isoform X2
plasma membrane calcium-transporting ATPase 4 isoform X3
zinc finger CCCH-type containing 11A, transcript variant X1
zinc finger CCCH-type containing 11A, transcript variant X2
zinc finger CCCH domain-containing protein 11A isoform X1
zinc finger CCCH domain-containing protein 11A isoform X2
small nuclear ribonucleoprotein polypeptide E
SRY-box transcription factor 13, transcript variant X1
SRY-box transcription factor 13, transcript variant X2
SRY-box transcription factor 13, transcript variant X3
ethanolamine kinase 2, transcript variant X2
ethanolamine kinase 2, transcript variant X1
ethanolamine kinase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pleckstrin homology domain containing A6, transcript variant X7
pleckstrin homology domain containing A6, transcript variant X3
pleckstrin homology domain containing A6, transcript variant X6
pleckstrin homology domain containing A6, transcript variant X8
pleckstrin homology domain containing A6, transcript variant X2
pleckstrin homology domain containing A6, transcript variant X1
pleckstrin homology domain containing A6, transcript variant X4
pleckstrin homology domain containing A6, transcript variant X5
pleckstrin homology domain containing A6, transcript variant X10
pleckstrin homology domain containing A6, transcript variant X9
pleckstrin homology domain containing A6, transcript variant X11
pleckstrin homology domain containing A6, transcript variant X12
pleckstrin homology domain-containing family A member 6 isoform X5
pleckstrin homology domain-containing family A member 6 isoform X4
pleckstrin homology domain-containing family A member 6 isoform X7
pleckstrin homology domain-containing family A member 6 isoform X3
pleckstrin homology domain-containing family A member 6 isoform X6
pleckstrin homology domain-containing family A member 6 isoform X8
pleckstrin homology domain-containing family A member 6 isoform X2
pleckstrin homology domain-containing family A member 6 isoform X1
pleckstrin homology domain-containing family A member 6 isoform X9
pleckstrin homology domain-containing family A member 6 isoform X10
protein phosphatase 1 regulatory subunit 15B
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
leucine rich repeat neuronal 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
leucine rich repeat neuronal 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
leucine rich repeat neuronal 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
retinoblastoma-binding protein 5 isoform X6
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X5
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X3
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X1
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X4
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X2
retinoblastoma-binding protein 5 isoform X5
retinoblastoma-binding protein 5 isoform X3
retinoblastoma-binding protein 5 isoform X1
retinoblastoma-binding protein 5 isoform X4
retinoblastoma-binding protein 5 isoform X2
dual serine/threonine and tyrosine protein kinase, transcript variant X3
dual serine/threonine and tyrosine protein kinase, transcript variant X2
dual serine/threonine and tyrosine protein kinase, transcript variant X1
dual serine/threonine and tyrosine protein kinase, transcript variant X4
dual serine/threonine and tyrosine protein kinase isoform X1
dual serine/threonine and tyrosine protein kinase isoform X2
transmembrane and coiled-coil domain family 2
LOW QUALITY PROTEIN: transmembrane and coiled-coil domains protein 2
kelch domain containing 8A, transcript variant X3
kelch domain containing 8A, transcript variant X2
kelch domain containing 8A, transcript variant X1
kelch domain-containing protein 8A isoform X1
kelch domain-containing protein 8A isoform X2
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
BLACAT1 overlapping LEMD1 locus, transcript variant X5
BLACAT1 overlapping LEMD1 locus, transcript variant X2
BLACAT1 overlapping LEMD1 locus, transcript variant X4
BLACAT1 overlapping LEMD1 locus, transcript variant X1
BLACAT1 overlapping LEMD1 locus, transcript variant X3
bladder cancer associated transcript 1 isoform X1
bladder cancer associated transcript 1 isoform X2
bladder cancer associated transcript 1 isoform X3
cyclin dependent kinase 18, transcript variant X1
cyclin dependent kinase 18, transcript variant X2
major facilitator superfamily domain containing 4A
major facilitator superfamily domain-containing protein 4A
ETS transcription factor ELK4, transcript variant X2
ETS transcription factor ELK4, transcript variant X1
ETS transcription factor ELK4, transcript variant X4
ETS transcription factor ELK4, transcript variant X3
Krueppel-like factor 15, transcript variant X1
Krueppel-like factor 15, transcript variant X3
Krueppel-like factor 15, transcript variant X2
Krueppel-like factor 15, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 45 member 3, transcript variant X2
solute carrier family 45 member 3, transcript variant X12
solute carrier family 45 member 3, transcript variant X10
solute carrier family 45 member 3, transcript variant X11
solute carrier family 45 member 3, transcript variant X9
solute carrier family 45 member 3, transcript variant X8
solute carrier family 45 member 3, transcript variant X7
solute carrier family 45 member 3, transcript variant X1
solute carrier family 45 member 3, transcript variant X3
solute carrier family 45 member 3, transcript variant X4
solute carrier family 45 member 3, transcript variant X5
solute carrier family 45 member 3, transcript variant X6
nuclear casein kinase and cyclin dependent kinase substrate 1, transcript variant X1
nuclear casein kinase and cyclin dependent kinase substrate 1, transcript variant X2
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 isoform X2
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
solute carrier family 41 member 1, transcript variant X4
solute carrier family 41 member 1, transcript variant X5
solute carrier family 41 member 1, transcript variant X3
solute carrier family 41 member 1, transcript variant X2
solute carrier family 41 member 1, transcript variant X1
N-fatty-acyl-amino acid synthase/hydrolase PM20D1
RAB7B, member RAS oncogene family, transcript variant X3
RAB7B, member RAS oncogene family, transcript variant X2
RAB7B, member RAS oncogene family, transcript variant X1
regulator of hemoglobinization and erythroid cell expansion
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
regulator of hemoglobinization and erythroid cell expansion protein
family with sequence similarity 72 member A
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X1
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X3
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X5
SLIT-ROBO Rho GTPase-activating protein 2 isoform X1
SLIT-ROBO Rho GTPase-activating protein 2 isoform X3
SLIT-ROBO Rho GTPase-activating protein 2 isoform X5
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X4
SLIT-ROBO Rho GTPase activating protein 2, transcript variant X2
SLIT-ROBO Rho GTPase-activating protein 2 isoform X2
SLIT-ROBO Rho GTPase-activating protein 2 isoform X4
cyclin-dependent kinase 18-like, transcript variant X2
cyclin-dependent kinase 18-like, transcript variant X1
cyclin-dependent kinase 18-like, transcript variant X3
cyclin-dependent kinase 18-like, transcript variant X4
cyclin-dependent kinase 18-like isoform X2
cyclin-dependent kinase 18-like isoform X3
cyclin-dependent kinase 18-like isoform X1
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X3
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X1
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X1
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X4
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X3
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X2
Ras association domain family member 5, transcript variant X3
ras association domain-containing protein 5 isoform X3
Ras association domain family member 5, transcript variant X6
ras association domain-containing protein 5 isoform X6
Ras association domain family member 5, transcript variant X1
Ras association domain family member 5, transcript variant X5
ras association domain-containing protein 5 isoform X1
ras association domain-containing protein 5 isoform X5
Ras association domain family member 5, transcript variant X4
ras association domain-containing protein 5 isoform X4
Ras association domain family member 5, transcript variant X2
ras association domain-containing protein 5 isoform X2
Ras association domain family member 5, transcript variant X7
ras association domain-containing protein 5 isoform X7
eukaryotic translation initiation factor 2D, transcript variant X1
eukaryotic translation initiation factor 2D, transcript variant X2
eukaryotic translation initiation factor 2D isoform X1
eukaryotic translation initiation factor 2D isoform X2
dual specificity tyrosine phosphorylation regulated kinase 3
dual specificity tyrosine-phosphorylation-regulated kinase 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
polymeric immunoglobulin receptor-like, transcript variant X1
polymeric immunoglobulin receptor-like, transcript variant X3
polymeric immunoglobulin receptor-like, transcript variant X2
polymeric immunoglobulin receptor-like isoform X1
polymeric immunoglobulin receptor-like isoform X2
chromosome 24 C1orf116 homolog, transcript variant X2
chromosome 24 C1orf116 homolog, transcript variant X1
specifically androgen-regulated gene protein
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X6
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X3
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X4
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X5
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X5
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X4
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X3
complement C3b/C4b receptor 1 (Knops blood group)
CD55 molecule (Cromer blood group), transcript variant X1
CD55 molecule (Cromer blood group), transcript variant X2
membrane cofactor protein-like, transcript variant X1
membrane cofactor protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
membrane cofactor protein-like, transcript variant X4
membrane cofactor protein-like, transcript variant X2
membrane cofactor protein-like isoform X3
membrane cofactor protein-like isoform X2
membrane cofactor protein-like isoform X4
membrane cofactor protein-like isoform X1
uncharacterized LOC125338123, transcript variant X2
uncharacterized LOC125338123, transcript variant X1
hematopoietic progenitor cell antigen CD34 isoform X1
hematopoietic progenitor cell antigen CD34 isoform X3
hematopoietic progenitor cell antigen CD34 isoform X2
calcium/calmodulin dependent protein kinase IG
calcium/calmodulin-dependent protein kinase type 1G
laminin subunit beta 3, transcript variant X6
laminin subunit beta 3, transcript variant X7
laminin subunit beta 3, transcript variant X3
laminin subunit beta 3, transcript variant X5
laminin subunit beta 3, transcript variant X2
laminin subunit beta 3, transcript variant X1
laminin subunit beta 3, transcript variant X8
laminin subunit beta 3, transcript variant X4
11-beta-hydroxysteroid dehydrogenase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
11-beta-hydroxysteroid dehydrogenase 1-like, transcript variant X1
11-beta-hydroxysteroid dehydrogenase 1-like isoform X2
11-beta-hydroxysteroid dehydrogenase 1-like isoform X1
11-beta-hydroxysteroid dehydrogenase 1-like
TRAF3 interacting protein 3, transcript variant X1
TRAF3 interacting protein 3, transcript variant X7
TRAF3 interacting protein 3, transcript variant X4
TRAF3 interacting protein 3, transcript variant X3
TRAF3 interacting protein 3, transcript variant X6
TRAF3 interacting protein 3, transcript variant X2
TRAF3-interacting JNK-activating modulator isoform X1
TRAF3-interacting JNK-activating modulator isoform X4
TRAF3-interacting JNK-activating modulator isoform X6
TRAF3-interacting JNK-activating modulator isoform X3
TRAF3-interacting JNK-activating modulator isoform X7
TRAF3 interacting protein 3, transcript variant X5
TRAF3-interacting JNK-activating modulator isoform X2
TRAF3-interacting JNK-activating modulator isoform X5
interferon regulatory factor 6, transcript variant X1
interferon regulatory factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
putative uncharacterized protein GUCA1ANB
uncharacterized protein C6orf132 homolog
ATP synthase peripheral stalk-membrane subunit b
ATP synthase F(0) complex subunit B1, mitochondrial
transmembrane protein C1orf162 homolog, transcript variant X1
transmembrane protein C1orf162 homolog, transcript variant X2
transmembrane protein C1orf162 homolog isoform X1
transmembrane protein C1orf162 homolog isoform X2
RAP1A, member of RAS oncogene family, transcript variant X1
RAP1A, member of RAS oncogene family, transcript variant X2
inka box actin regulator 2, transcript variant X2
inka box actin regulator 2, transcript variant X5
inka box actin regulator 2, transcript variant X3
inka box actin regulator 2, transcript variant X6
inka box actin regulator 2, transcript variant X1
inka box actin regulator 2, transcript variant X4
probable ATP-dependent RNA helicase DDX20
potassium voltage-gated channel subfamily D member 3, transcript variant X1
potassium voltage-gated channel subfamily D member 3, transcript variant X6
potassium voltage-gated channel subfamily D member 3, transcript variant X4
potassium voltage-gated channel subfamily D member 3, transcript variant X2
potassium voltage-gated channel subfamily D member 3, transcript variant X3
potassium voltage-gated channel subfamily D member 3, transcript variant X5
potassium voltage-gated channel subfamily D member 3 isoform X2
potassium voltage-gated channel subfamily D member 3 isoform X1
CTTNBP2 N-terminal like, transcript variant X3
CTTNBP2 N-terminal like, transcript variant X4
CTTNBP2 N-terminal like, transcript variant X2
CTTNBP2 N-terminal like, transcript variant X1
CTTNBP2 N-terminal like, transcript variant X5
CTTNBP2 N-terminal-like protein isoform X1
CTTNBP2 N-terminal-like protein isoform X2
Wnt family member 2B, transcript variant X1
Wnt family member 2B, transcript variant X2
suppression of tumorigenicity 7 like, transcript variant X6
suppression of tumorigenicity 7 like, transcript variant X2
suppression of tumorigenicity 7 like, transcript variant X3
suppressor of tumorigenicity 7 protein-like isoform X6
suppressor of tumorigenicity 7 protein-like isoform X3
suppressor of tumorigenicity 7 protein-like isoform X2
suppression of tumorigenicity 7 like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
suppression of tumorigenicity 7 like, transcript variant X4
suppression of tumorigenicity 7 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
suppression of tumorigenicity 7 like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
suppressor of tumorigenicity 7 protein-like isoform X5
suppressor of tumorigenicity 7 protein-like isoform X4
suppressor of tumorigenicity 7 protein-like isoform X1
suppressor of tumorigenicity 7 protein-like isoform X7
capping actin protein of muscle Z-line subunit alpha 1
Mov10 RISC complex RNA helicase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Mov10 RISC complex RNA helicase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ras homolog family member C, transcript variant X3
ras homolog family member C, transcript variant X2
ras homolog family member C, transcript variant X1
rho-related GTP-binding protein RhoC isoform X2
rho-related GTP-binding protein RhoC isoform X1
rho-related GTP-binding protein RhoC isoform X3
protein phosphatase, Mg2+/Mn2+ dependent 1J
TAFA chemokine like family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TAFA chemokine like family member 3, transcript variant X4
TAFA chemokine like family member 3, transcript variant X8
TAFA chemokine like family member 3, transcript variant X3
TAFA chemokine like family member 3, transcript variant X2
TAFA chemokine like family member 3, transcript variant X1
TAFA chemokine like family member 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
TAFA chemokine like family member 3, transcript variant X6
TAFA chemokine like family member 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TAFA chemokine like family member 3, transcript variant X10
chemokine-like protein TAFA-3 isoform X3
chemokine-like protein TAFA-3 isoform X2
chemokine-like protein TAFA-3 isoform X6
chemokine-like protein TAFA-3 isoform X1
chemokine-like protein TAFA-3 isoform X7
chemokine-like protein TAFA-3 isoform X4
chemokine-like protein TAFA-3 isoform X5
chemokine-like protein TAFA-3 isoform X8
solute carrier family 16 member 1, transcript variant X2
solute carrier family 16 member 1, transcript variant X1
leucine rich repeats and immunoglobulin like domains 2
leucine-rich repeats and immunoglobulin-like domains protein 2
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X1
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X2
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X3